Company: LHI
Filing Date: 2025-08-08
Form Type: F-1/A
Source: 0001213900-25-073646
Chunk: 35

Company: Living Homeopathy International Ltd.
Filing Date: 2025-08-08
Form: F-1/A
Chunk 35
---
 in 2023, we have adopted the quality control practice of sending samples of existing products to HK STC approximately
once or twice a year and sending samples of new products for testing at Hong Kong STC prior to making any sales. See “Business – Quality Control” on page 82 of this prospectus for further details. Despite the quality control practice, if any of
the products we sell are believed to cause injury, not safe or cause an adverse effect. We may face the risk of product liability, which
could adversely affect our business, financial condition and results of operations. Product liability might be brought against us by
regulators, consumers, or others coming into contact with our products. As of the date of this prospectus, we are not aware of any product
liability claim against us. However, if any human consumption of our products results in any harmful side effective, consumers may bring
legal actions against us for damages and regulators may bring investigations or other proceedings against us, which may result in our
exposure to monetary and non-monetary penalties. Any of these may materially and adversely affect our business, operations, growth potential,
financial condition and results of operations.

We could be subject to negative publicity from time to time. Neither can we rule out the possibility that any existing negative publicity on any of our products, including LIVING Colloidal Silver, or any future publicity would result in claims or disputes .Our marketing and sale of products could also expose us to product liability and false marketing risks that are inherent in the testing, manufacturing and marketing of such products. Failure to maintain policies and procedures, obtain or maintain sufficient product liability insurance or otherwise protect or successfully defend, against product liability or false marketing claims could prevent or delay the commercialization or marketing of our products or future potential products or expose us to substantial liabilities and diversions of resources, all of which may materially and adversely affect our business, financial condition and results of operations. Regardless of the merit or eventual outcome, product liability or false marketing claims may result in:

| ● | impairment                                                           
 of our business reputation and significant negative media attention; |

| ● | withdrawal    
 of suppliers; |

| ● | significant                                                   
 costs to defend any related regulatory actions or litigation; |

| ● | significant                                                                                
 monetary liabilities to customers if determined that we are liable, settlement cost and/or 
 medical bills;                                                                             |

| ● | distraction                                          
 of management’s attention from our primary business; |

| ● | substantial                                                               
 monetary penalties or awards to regulators,